Scotland · NHS Scotland MSAN
Butec® (buprenorphine) 15microgram/hour transdermal patches (7-day)
MSAN(2020)118 · Level 2 · issued 29 Dec 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| remain available. | Available | — |
| remain available (see actions required below) | Available | — |
| * This product remains available, however, can only support partial uplift in demand. Please liaise with your | Available — partial uplift only | — |
| * This product remains available, however, can only support partial uplift in demand. Please liaise with | Available — partial uplift only | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.